Individuals living with HIV who are optimally treated with combination antiretroviral therapy
(cART) can now lead an extended life. In spite of this remarkable survival benefit from viral …

Antiretroviral therapy has largely transformed HIV infection into a chronic disease condition.
As such, physicians and other providers caring for individuals living with HIV infection need …

Abstract An Expert Panel convened by the National Lipid Association previously developed
a consensus set of recommendations for the patient-centered management of dyslipidemia …

Background Carotid intima-media thickness (cIMT) is related to the risk of cardiovascular
events in the general population. An association between changes in cIMT and …

Context: Metabolic changes and smoking are common among HIV patients and may confer
increased cardiovascular risk. Objective: The aim of the study was to determine acute …

In the last 25 years, HIV-1, the retrovirus responsible for the acquired immunodeficiency
syndrome (AIDS), has gone from being an “inherently untreatable” infectious agent to one …

Background: Coronary artery disease (CAD) has been associated with HIV infection, but
data are not consistent. Objective: To determine whether HIV-infected men have more …

It is currently unclear what causes the chronic inflammation within atherosclerotic plaques.
One emerging paradigm suggests that infection with bacteria and/or viruses can contribute …

Thorough research on HIV is progressively enabling us to understand the intricate
mechanisms that link HIV‐1 infection to the onset of immunodeficiency. The infection and …

Metabolic complications such as dyslipidemia, insulin resistance, and altered fat distribution
(loss of subcutaneous fat and relatively increased central fat) are common in adults infected …